Letters
Patient information on new drugs
Patient information on new drugs: almost insurmountable obstacles
BMJ 2024; 387 doi: https://doi.org/10.1136/bmj.q2866 (Published 30 December 2024) Cite this as: BMJ 2024;387:q2866
- Angus V P Mackay, retired consultant psychiatrist, independent adviser to the MHRA
- University of Glasgow, Glasgow, UK
- angus.mackay{at}glasgow.ac.uk
Davis and colleagues share their concern about the lack of accessible information on both the magnitude and nature of the benefits of new drugs.1 Without such information, it is impossible for patients, …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.